Shmueli, Moshe
Lendner, Idan
Ben-Shimol, Shalom
Article History
Received: 22 May 2023
Revised: 11 September 2023
Accepted: 15 September 2023
First Online: 20 September 2023
Declarations
:
: Shalom Ben-Shimol has received within the last 35 months grants by Pfizer. He serves as scientific consultant and on the review board of Pfizer and MSD, and belongs to the speaker bureau of Pfizer, MSD, and GSK. The other authors do not report any conflict of interest.